Author: Staff

US Equity Markets

Lixte Biotechnology (LIXT) Shares Climb Sharply On Equity Deal Closure

Following the successful conclusion of a $5.0 million private placement, Lixte Biotechnology Holdings, Inc. (NASDAQ: LIXT) saw a notable spike in its share price on Wednesday, ending at $2.02, representing a dramatic jump of 71.19%. In line with Nasdaq’s market-based

Investors Wish List

Shares Climb As Mogo Commits To Bitcoin-Focused Treasury Approach

Mogo Inc. (NASDAQ: MOGO) shares are experiencing a sharp surge in trading, climbing 99.17% to $2.41 at last check, after the company unveiled a bold strategic shift toward Bitcoin integration. The company’s Board of Directors has approved a plan to

Stocks Ride

Amaze Holdings (AMZE) Stock Regains Ground In Extended Session

Over the course of Monday’s extended session, shares of Amaze Holdings, Inc. (NYSE: AMZE) recovered, trading at $9.00, up 6.86%. Losses during the normal trading session, when the stock fell 11.74% to close at $8.42, were partially recovered by this

US Equity Markets

GlucoTrack (GCTK) Gains Momentum On Encouraging Clinical Data Release

After GlucoTrack, Inc. (NASDAQ: GCTK) released encouraging results from its first-in-human clinical research, the company’s shares surged 26.25% to $7.84 during the previous session. The results were presented last week in Chicago at the American Diabetes Association’s (ADA) 85th Scientific

Stocks Ride

Synergy (SNYR) Expands Global Reach, Boosting Investor Confidence

Synergy CHC Corp. (NASDAQ: SNYR) shares surged 19.91% last Friday, closing at $2.65, after the company disclosed a significant expansion to its global licensing strategy. Global Expansion Momentum The consumer health company stated that its contract with Gravity Pharma has

Stocks Ride

Market Movement For Scholar Rock (SRRK) As Phase 2 Results Impress

With a strong start to the day, Scholar Rock Holding Corporation (NASDAQ: SRRK) rose 13.77% to $35.44 as of the last check. The stock price increased following the biotechnology company’s release of positive results from a research trial. Apitegromab Enhances

Stocks Ride

Know Labs (KNW) Gains Momentum Following An Equity Deal

The U.S. stock market saw a sharp increase in Know Labs, Inc. (NYSE: KNW) on Monday, finishing 94.87% higher at $3.04 a share. This increase came after Goldeneye 1995 LLC, a company connected to fintech entrepreneur and former Ripple Chief

Comet Report
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.